Marcain-Adrenalin

Bupivacaine hydrochloride, the active ingredient in Marcain-Adrenalin, is a local anesthetic presented as a sterile injectable solution for epidural and infiltration use. It provides surgical anesthesia and analgesia for adult patients undergoing minor to major procedures. GNH USA supplies Marcain-Adrenalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Marcain-Adrenalin is a local anesthetic used in surgical and procedural settings to achieve nerve block and analgesia. - Surgical anesthesia: provides dense sensory block for operative procedures. - Epidural analgesia: prolongs pain relief during labor or postoperative period. - Infiltration anesthesia: enables local numbing for minor skin or soft‑tissue procedures.

Common Side Effects: - Transient numbness at the injection site - Mild hypotension - Bradycardia - Headache - Nausea - Dizziness Serious or Rare Side Effects: - Cardiac arrhythmia - Seizure - Severe allergic reaction (anaphylaxis) - Methemoglobinemia - Persistent motor block - Local anesthetic systemic toxicity (LAST)

Before administration, consider the following precautions: - Allergy assessment: verify no known hypersensitivity to bupivacaine, epinephrine or amide anesthetics. - Cardiovascular status: avoid in patients with severe conduction disorders or uncontrolled hypertension. - Dosage limits: adhere to maximum recommended dose to prevent systemic toxicity. - Concurrent CNS depressants: monitor for additive central nervous system effects. - Pregnancy and lactation: use only if benefit outweighs risk; consult obstetric specialist. - Store at room temperature: keep in original container, protect from light and moisture.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): increased risk of cardiotoxicity. - Beta‑blockers: may potentiate bradycardia and hypotension. - General anesthetics (e.g., halothane): additive CNS depression. - Monoamine oxidase inhibitors: may enhance epinephrine effects. - Concurrent use of other local anesthetics: cumulative toxicity risk. Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: monitor for increased bleeding risk due to vasoconstriction. - Diuretics: may alter plasma concentration, monitor blood pressure.